CPXX

Celator Pharmaceuticals Inc. (CPXX)

Celator Pharmaceuticals Inc. (MM)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CPXX

<< Previous 1 2 3 4 5 6 7 8 9 Next >>

Date	Time	Source	Headline	Symbol	Company
03/29/2016	4:52PM	PR Newswire (US)	Celator® Pharmaceuticals Closes $43.7 Million Underwritten Financing	NASDAQ:CPXX	Celator Pharmaceuticals Inc. (MM)
03/24/2016	6:13AM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:CPXX	Celator Pharmaceuticals Inc. (MM)
03/23/2016	5:19PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CPXX	Celator Pharmaceuticals Inc. (MM)
03/23/2016	9:14AM	PR Newswire (US)	Celator® Pharmaceuticals Announces Pricing Of A $38.0 Million Public Offering Of Common Stock	NASDAQ:CPXX	Celator Pharmaceuticals Inc. (MM)
03/23/2016	6:32AM	Edgar (US Regulatory)	Registration of Additional Securities (up to 20%) (s-3mef)	NASDAQ:CPXX	Celator Pharmaceuticals Inc. (MM)
03/22/2016	5:07PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:CPXX	Celator Pharmaceuticals Inc. (MM)
03/22/2016	4:01PM	PR Newswire (US)	Celator® Pharmaceuticals Announces Proposed Public Offering Of Common Stock	NASDAQ:CPXX	Celator Pharmaceuticals Inc. (MM)
03/21/2016	9:30AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CPXX	Celator Pharmaceuticals Inc. (MM)
03/21/2016	8:19AM	PR Newswire (US)	Celator® Pharmaceuticals Announces Business Update and Fourth Quarter and Full Year 2015 Financial Results	NASDAQ:CPXX	Celator Pharmaceuticals Inc. (MM)
03/14/2016	4:01PM	PR Newswire (US)	Celator Announces Phase 3 Trial for VYXEOS™ (CPX-351) in Patients with High-Risk Acute Myeloid Leukemia Demonstrates Statis...	NASDAQ:CPXX	Celator Pharmaceuticals Inc. (MM)
02/16/2016	3:55PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CPXX	Celator Pharmaceuticals Inc. (MM)
02/16/2016	7:00AM	PR Newswire (US)	Celator Pharmaceuticals Phase 3 Trial of VYXEOS™ (CPX-351) in Patients with High-Risk Acute Myeloid Leukemia Reaches Requir...	NASDAQ:CPXX	Celator Pharmaceuticals Inc. (MM)
02/01/2016	7:00AM	PR Newswire (US)	Celator® Pharmaceuticals to Present at BIO CEO and Investor Conference	NASDAQ:CPXX	Celator Pharmaceuticals Inc. (MM)
01/29/2016	4:09PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CPXX	Celator Pharmaceuticals Inc. (MM)
01/29/2016	4:07PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CPXX	Celator Pharmaceuticals Inc. (MM)
01/29/2016	4:04PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CPXX	Celator Pharmaceuticals Inc. (MM)
01/11/2016	7:00AM	PR Newswire (US)	Celator® Pharmaceuticals Announces Participation in Cardiff University Clinical Trial in Adults with Acute Myeloid Leukemia ...	NASDAQ:CPXX	Celator Pharmaceuticals Inc. (MM)
01/06/2016	7:00AM	PR Newswire (US)	Celator® Pharmaceuticals to Present at Biotech Showcase 2016	NASDAQ:CPXX	Celator Pharmaceuticals Inc. (MM)
12/08/2015	7:00AM	PR Newswire (US)	Celator® Pharmaceuticals Announces Positive Data Showing VYXEOS™ Benefit in Patients with AML	NASDAQ:CPXX	Celator Pharmaceuticals Inc. (MM)
12/07/2015	10:56AM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CPXX	Celator Pharmaceuticals Inc. (MM)
12/04/2015	4:31PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CPXX	Celator Pharmaceuticals Inc. (MM)
12/01/2015	7:00AM	PR Newswire (US)	Celator® Pharmaceuticals to Present Data at the 57th American Society of Hematology Annual Meeting	NASDAQ:CPXX	Celator Pharmaceuticals Inc. (MM)
11/19/2015	7:00AM	PR Newswire (US)	Celator® Pharmaceuticals Receives Allowance of Expanded U.S. Claims on CombiPlex® Technology	NASDAQ:CPXX	Celator Pharmaceuticals Inc. (MM)
11/12/2015	5:31PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CPXX	Celator Pharmaceuticals Inc. (MM)
11/12/2015	4:05PM	PR Newswire (US)	Celator® Pharmaceuticals Announces Third Quarter 2015 Financial Results and Business Update	NASDAQ:CPXX	Celator Pharmaceuticals Inc. (MM)
11/11/2015	7:00AM	PR Newswire (US)	Celator® Pharmaceuticals to Receive More Than $1.675 Million from New Jersey's Technology Business Tax Certificate Transfer ...	NASDAQ:CPXX	Celator Pharmaceuticals Inc. (MM)
11/10/2015	7:00AM	PR Newswire (US)	Celator® Pharmaceuticals Presents Positive Results from R&D Programs	NASDAQ:CPXX	Celator Pharmaceuticals Inc. (MM)
11/05/2015	7:00AM	PR Newswire (US)	Celator® Pharmaceuticals to Report Third Quarter 2015 Financial Results on November 12, 2015	NASDAQ:CPXX	Celator Pharmaceuticals Inc. (MM)
10/29/2015	7:00AM	PR Newswire (US)	Celator® Pharmaceuticals to Present Data at the AACR-NCI-EORTC International Conference	NASDAQ:CPXX	Celator Pharmaceuticals Inc. (MM)
10/27/2015	7:00AM	PR Newswire (US)	Celator® Pharmaceuticals Announces VYXEOS™ (CPX-351) Selected As Best Nanomedicine Product	NASDAQ:CPXX	Celator Pharmaceuticals Inc. (MM)